Rheumatoid Arthritis: Pathogenesis, Complications and Treatment recommendations

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disorder characterized primarily by persistent inflammation of synovial joints, leading to joint destruction, disability, and increased morbidity and mortality. Affecting approximately 1.3 million adults in the United States, RA is a debilitating disease that demands early recognition and aggressive management. Genetic predisposition, environmental triggers, and an abnormal immune response converge to initiate the pathogenesis of RA. Without prompt intervention, the disease progresses to joint deformity, systemic complications, and a significant decline in quality of life.

This CE course is designed for physicians, nurses, and physician assistants practicing in specialties such as Rheumatology, Internal Medicine, Primary Care, and Family Medicine. It provides comprehensive insights into the pathophysiology of RA, with a detailed focus on proinflammatory cytokines, immune mechanisms, and genetic markers. The course further elaborates on the clinical manifestations, diagnostic approach, and updated treatment guidelines, including disease-modifying antirheumatic drugs (DMARDs), biologics, and targeted synthetic agents. Healthcare professionals will gain the tools necessary to improve patient care, relieve symptoms, slow disease progression, and enhance functional outcomes through evidence-based approaches and shared decision-making.

Educational Objectives

• Explain the genetic, environmental, and immunological factors contributing to the pathogenesis of rheumatoid arthritis.
• Identify the clinical signs, symptoms, and complications commonly associated with rheumatoid arthritis.
• Apply evidence-based treatment protocols to manage rheumatoid arthritis, including DMARDs, biologics, and supportive care.

Who Should Do This Course

This course is ideal for healthcare professionals involved in diagnosing and treating patients with chronic inflammatory or autoimmune disorders. It is especially relevant for:

• Physicians specializing in Rheumatology, Internal Medicine, Family Medicine, and General Practice
• Nurse Practitioners and Registered Nurses focusing on Primary Care, Allergy and Immunology, or Chronic Disease Management
• Physician Assistants providing musculoskeletal or autoimmune care

This course equips providers with the knowledge to improve early detection, therapeutic planning, and long-term management of patients with rheumatoid arthritis.

Did You Know?

• Approximately 1.3 million people in the United States are living with rheumatoid arthritis (Arthritis Foundation).
• RA is 2 to 3 times more common in women than in men (CDC, 2023).
• Early treatment with DMARDs can reduce long-term joint damage and improve life expectancy (American College of Rheumatology, 2023).
• Rheumatoid arthritis increases the risk of cardiovascular disease, making early management even more critical (Mayo Clinic, 2022).